10x Genomics dips 15%

By George Banko

July 10, 2024

Good Morning Wake-Up Watchlisters! While you’re drinking a summer berry refresher you’ll see stock futures were up on Wednesday. The S&P 500 is up 17% so far this year, and tech stocks like Nvidia have accounted for more than a third of the S&P 500’s gains this year. But as focus shifts to earnings, this new season could mark the end of tech company dominance and usher in new growth in other sectors.

As earnings season gets underway with big banks reporting later this week, it’s crucial to know how to trade earnings without taking unnecessary risks. Our Lead Technical Tactician Nate Bear has a proven way for making consistent winning trades AFTER a stock reports earnings. Since he started using this strategy, he’s closed 72 winning trades for 10.49% average return and a 79% win rate.

Click here to learn about Nate’s post-earnings surge pattern and how you can use it during earnings season.

Here’s a look at the top-moving stocks this morning.

10x Genomics (Nasdaq: TXG)

10x Genomics is down 15.07% in premarket trading after Goldman Sachs lowered their price target on the stock from $26 to $16. Goldman Sachs currently has a sell rating on the stock.

A stock going down doesn’t mean you can’t still find ways to profit. Our Head Trading Tactician Bryan Bottarelli uses what he calls “overnight trades.” This strategy involves one simple trade at the end of the day – and has the potential to DOUBLE your money overnight.

Click here to see how overnight trading works.

Baidu (Nasdaq: BIDU)

Baidu, Inc. is up 3.07% in premarket trading after soaring to record highs due to growing popularity for its Apollo Go robotaxi in China. The stock rose by as much as 13% in Hong Kong, following an 8.5% advance in the US on Tuesday.

Illumina, Inc. (Nasdaq: ILMN)

Illumina is up 3.72% in premarket trading after the DNA sequencing and array-based technologies company announced that effective today it has acquired Fluent Biosciences. The acquisition closed on July 9, 2024.